Select Page

ColoScape™ Colorectal Cancer Mutation Detection Test Service

Improved Sensitivity for Colorectal Cancer Mutation Detection

ColoScape™ Colorectal Cancer Mutation Detection Test is a novel highly sensitive in vitro diagnostic assay using the qPCR-based multi-gene panel for the qualitative detection of colorectal cancer-associated gene mutations in liquid biopsy and FFPE tissue samples. The kit utilizes our XNA technology which leverages a sequence-specific clamp made by xeno-nucleic acid (XNA) to suppress PCR amplification of wild-type DNA template and selectively amplify only mutant DNA template, reaching sensitivity at 0.1% to 0.5% Variant Allele Frequency (VAF) with 10 ng DNA input. The detection kit identifies the presence or absence of mutations in the targeted regions of four colon cancer-associated genes.

The assay can be performed on qPCR instrumentation that is already available in hospital pathology laboratories. Unlike other colorectal cancer tests on the market, ColoScape™ provides a comprehensive profile of the key colorectal cancer ‘driver’ and ‘resistance’ mutations (gene variation landscape) and offers oncologists valuable information to evaluate targeted therapy options. ColoScape™ could also be used to complement existing colorectal cancer detection tests.

Contact DiaCarta to order ColoScape™Colorectal Cancer Mutation Detection Test Service.

Call +1 800-246-8878

Email: order@diacarta.com

 

Need Help?

Call us: +1 (800) 246-8878

Email us: information@diacarta.com

Contact Us!

Ready to Subscribe and Learn?

Register and Learn!

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!

X